Krishnan, P; Gupta, R T; Boll, D T; Brady, C M; Husarik, D B; Merkle, E M (2012). Functional evaluation of cystic duct patency with Gd-EOB-DTPA MR imaging: an alternative to hepatobiliary scintigraphy for diagnosis of acute cholecystitis? Abdominal Imaging, 37(3):457-464.
Gupta, R T; Marin, D; Boll, D T; Husarik, D B; Davis, D E; Feuerlein, S; Merkle, E M (2012). Hepatic hemangiomas: Difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. European Journal of Radiology, 81(10):2457-2462.
Bashir, M R; Husarik, D B; Ziemlewicz, T J; Gupta, R T; Boll, D T; Merkle, E M (2012). Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: Does increasing the flip angle improve conspicuity and detection rate of hypointense lesions? Journal of Magnetic Resonance Imaging, 35(3):611-616.
Husarik, D B; Gupta, R T; Ringe, K I; Boll, D T; Merkle, E M (2011). Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: Inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Academic Radiology, 18(12):1549-1554.
Husarik, D B; Boll, D T; Nelson, R C; Merkle, E M (2011). Low-dose unenhanced CT for IV contrast bolus timing: is it reliable to assess hepatic steatosis? Academic Radiology, 18(7):822-827.
Fink, C; Alkadhi, H; Boll, D T; Johnson, T; Kachelrie, M (2010). Advances in CT technology. Investigative Radiology, 45(6):289.